Chemical Compound Review:
AC1NWALC 4-[(3S,5R,10S,13R,14S,17S)-3- [(2R,4S,5S...
Synonyms:
BSPBio_002205, KBioGR_001087, KBioSS_001444, CCG-38362, NINDS_000036, ...
Gabrielson,
Hogue,
Bohr,
Cardounel,
Nakajima,
Kofler,
Zweier,
Rodriguez,
Martin,
de Souza-Pinto,
Bressler,
Wright,
Wang,
Kallen,
Wang,
Burke,
Olson,
Cusack,
Gambliel,
Dillmann,
Walsh,
Annunziato,
Frossard,
Knol,
Levander,
Nicolas,
Taglialatela,
Tharp,
Tillement,
Timmerman,
Pedersen,
Denollet,
Daemen,
van de Sande,
de Jaegere,
Serruys,
Erdman,
van Domburg,
Westenberg,
Zünkler,
Dosh,
- Hyperthermia potentiates doxorubicin-related cardiotoxic effects. Kim, Y.D., Lees, D.E., Lake, C.R., Whang-Peng, J., Schuette, W., Smith, R., Bull, J. JAMA (1979)
- Pharmacokinetics and mechanism of action of a doxorubicin-monoclonal antibody 9.2.27 conjugate directed to a human melanoma proteoglycan. Yang, H.M., Reisfeld, R.A. J. Natl. Cancer Inst. (1988)
- A novel mouse model of lipotoxic cardiomyopathy. Chiu, H.C., Kovacs, A., Ford, D.A., Hsu, F.F., Garcia, R., Herrero, P., Saffitz, J.E., Schaffer, J.E. J. Clin. Invest. (2001)
- erbB2 is required for G protein-coupled receptor signaling in the heart. Negro, A., Brar, B.K., Gu, Y., Peterson, K.L., Vale, W., Lee, K.F. Proc. Natl. Acad. Sci. U.S.A. (2006)
- Plasma endothelin determination as a prognostic indicator of 1-year mortality after acute myocardial infarction. Omland, T., Lie, R.T., Aakvaag, A., Aarsland, T., Dickstein, K. Circulation (1994)
- Fatigue, depressive symptoms, and hopelessness as predictors of adverse clinical events following percutaneous coronary intervention with paclitaxel-eluting stents. Pedersen, S.S., Denollet, J., Daemen, J., van de Sande, M., de Jaegere, P.T., Serruys, P.W., Erdman, R.A., van Domburg, R.T. Journal of psychosomatic research (2007)
- Developments in the drug treatment of panic disorder: what is the place of the selective serotonin reuptake inhibitors? Westenberg, H.G. Journal of affective disorders. (1996)
- Motor nerve blockade potency and toxicity of non-racemic bupivacaine in rats. Trachez, M.M., Zapata-Sudo, G., Moreira, O.R., Chedid, N.G., Russo, V.F., Russo, E.M., Sudo, R.T. Acta anaesthesiologica Scandinavica. (2005)
- Diagnosis of heart failure in adults. Dosh, S.A. American family physician. (2004)
- Sarafotoxin, a novel vasoconstrictor peptide: phosphoinositide hydrolysis in rat heart and brain. Kloog, Y., Ambar, I., Sokolovsky, M., Kochva, E., Wollberg, Z., Bdolah, A. Science (1988)
- Amoxapine overdose. Coma and seizures without cardiotoxic effects. Kulig, K., Rumack, B.H., Sullivan, J.B., Brandt, H., Spyker, D.A., Duffy, J.P., Shipe, J.R. JAMA (1982)
- Systemic toxic effects associated with high-dose verapamil infusion and chemotherapy administration. Pennock, G.D., Dalton, W.S., Roeske, W.R., Appleton, C.P., Mosley, K., Plezia, P., Miller, T.P., Salmon, S.E. J. Natl. Cancer Inst. (1991)
- Anthracycline-induced cardiotoxicity. Shan, K., Lincoff, A.M., Young, J.B. Ann. Intern. Med. (1996)
- HERG, a primary human ventricular target of the nonsedating antihistamine terfenadine. Roy, M., Dumaine, R., Brown, A.M. Circulation (1996)
- Mitochondrial toxin 3-nitropropionic acid induces cardiac and neurotoxicity differentially in mice. Gabrielson, K.L., Hogue, B.A., Bohr, V.A., Cardounel, A.J., Nakajima, W., Kofler, J., Zweier, J.L., Rodriguez, E.R., Martin, L.J., de Souza-Pinto, N.C., Bressler, J. Am. J. Pathol. (2001)
- Differences in steady-state inactivation between Na channel isoforms affect local anesthetic binding affinity. Wright, S.N., Wang, S.Y., Kallen, R.G., Wang, G.K. Biophys. J. (1997)
- Chairman's overview. The place of reboxetine in antidepressant therapy. Montgomery, S.A. The Journal of clinical psychiatry. (1998)
- Phase I trial of adjuvant chemotherapy with cyclophosphamide, epirubicin and 5-fluorouracil (CEF) for stage II breast cancer. Jones, S.E., Mennel, R.G., Peters, G.N., Westrick, M.A., Brooks, B.D., Knox, S.M., McGuffey, P. Investigational new drugs. (1988)
- Effects of alpha-adrenoceptor agonists and antagonists on ouabain-induced arrhythmias and cardiac arrest in guinea-pig. Thomas, G.P., Tripathi, R.M. Br. J. Pharmacol. (1986)
- Cardiotoxicity and comparative pharmacokinetics of six anthracyclines in the rabbit. Jaenke, R.S., Deprez-DeCampeneere, D., Trouet, A. Cancer Res. (1980)
- Molecular mechanisms of doxorubicin-induced cardiomyopathy. Selective suppression of Reiske iron-sulfur protein, ADP/ATP translocase, and phosphofructokinase genes is associated with ATP depletion in rat cardiomyocytes. Jeyaseelan, R., Poizat, C., Wu, H.Y., Kedes, L. J. Biol. Chem. (1997)
- Human ether-a-go-go-related (HERG) gene and ATP-sensitive potassium channels as targets for adverse drug effects. Zünkler, B.J. Pharmacol. Ther. (2006)
- New insights into the second generation antihistamines. Walsh, G.M., Annunziato, L., Frossard, N., Knol, K., Levander, S., Nicolas, J.M., Taglialatela, M., Tharp, M.D., Tillement, J.P., Timmerman, H. Drugs (2001)
- Clinical decision making based on radionuclide determined ejection fraction in oncology patients. Peng, N.J., Advani, R., Kopiwoda, S., Fisher, G., Strauss, H.W. J. Nucl. Med. (1997)
- Endomyocardial disease and eosinophilia. Report of a case. Jaski, B.E., Goetzl, E.J., Said, J.W., Fishbein, M.C. Circulation (1978)
- Cardiotoxic effects of the plasticizer metabolite, mono (2-ethylhexyl)phthalate (MEHP), on human myocardium. Barry, Y.A., Labow, R.S., Rock, G., Keon, W.J. Blood (1988)
- Analyses of the molecular mechanism of adriamycin-induced cardiotoxicity. Gille, L., Nohl, H. Free Radic. Biol. Med. (1997)
- Biochemical and pharmacological properties of a cardiotoxic factor isolated from the blood serum of burned patients. Moati, F., Sepulchre, C., Miskulin, M., Huisman, O., Moczar, E., Robert, A.M., Monteil, R., Guilbaud, J. J. Pathol. (1979)
- Haemodynamic side effects of antilymphocyte serum. de Groot, P., Schipperheyn, J.J., Huisman, P., Kroll, K., van der Does, J.A. Transplantation (1977)
- Role of (+-)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane (ICRF-187) in modulating free radical scavenging enzymes in doxorubicin-induced cardiomyopathy. Alderton, P., Gross, J., Green, M.D. Cancer Res. (1990)
- Clinical and pharmacologic study of the epirubicin and paclitaxel combination in women with metastatic breast cancer. Grasselli, G., Viganò, L., Capri, G., Locatelli, A., Tarenzi, E., Spreafico, C., Bertuzzi, A., Giani, A., Materazzo, C., Cresta, S., Perotti, A., Valagussa, P., Gianni, L. J. Clin. Oncol. (2001)
- Synthesis of shock proteins in cultured fetal mouse myocardial cells. Löw, I., Friedrich, T., Schoeppe, W. Exp. Cell Res. (1989)
- Temporal changes in endocardial energy metabolism following propranolol and the metabolic basis for protection against isoprenaline cardiotoxicity. Pieper, G.M., Clayton, F.C., Todd, G.L., Eliot, R.S. Cardiovasc. Res. (1979)
- Effects of ouabain on technetium-99m-Q12 and thallium-201 extraction and retention by isolated rat heart. McGoron, A.J., Gerson, M.C., Biniakiewicz, D.S., Washburn, L.C., Millard, R.W. J. Nucl. Med. (1996)
- Blockade of NF-kappaB improves cardiac function and survival without affecting inflammation in TNF-alpha-induced cardiomyopathy. Kawamura, N., Kubota, T., Kawano, S., Monden, Y., Feldman, A.M., Tsutsui, H., Takeshita, A., Sunagawa, K. Cardiovasc. Res. (2005)
- Differential cardiotoxic/cardioprotective effects of beta-adrenergic receptor subtypes in myocytes and fibroblasts in doxorubicin cardiomyopathy. Fajardo, G., Zhao, M., Powers, J., Bernstein, D. J. Mol. Cell. Cardiol. (2006)
- Cyclooxygenase-2 inhibition and coagulation. Steffel, J., Lüscher, T.F., Ruschitzka, F., Tanner, F.C. J. Cardiovasc. Pharmacol. (2006)
- Anthracycline cardiotoxicity in transgenic mice overexpressing SR Ca2+-ATPase. Burke, B.E., Olson, R.D., Cusack, B.J., Gambliel, H.A., Dillmann, W.H. Biochem. Biophys. Res. Commun. (2003)
- Peroxynitrite, the breakdown product of nitric oxide, is beneficial in blood cardioplegia but injurious in crystalloid cardioplegia. Ronson, R.S., Thourani, V.H., Ma, X.L., Katzmark, S.L., Han, D., Zhao, Z.Q., Nakamura, M., Guyton, R.A., Vinten-Johansen, J. Circulation (1999)
- Design and interpretation of clinical trials that evaluate agents that may offer protection from the toxic effects of cancer chemotherapy. Phillips, K.A., Tannock, I.F. J. Clin. Oncol. (1998)
- Phase I crossover study of paclitaxel with r-verapamil in patients with metastatic breast cancer. Tolcher, A.W., Cowan, K.H., Solomon, D., Ognibene, F., Goldspiel, B., Chang, R., Noone, M.H., Denicoff, A.M., Barnes, C.S., Gossard, M.R., Fetsch, P.A., Berg, S.L., Balis, F.M., Venzon, D.J., O'Shaughnessy, J.A. J. Clin. Oncol. (1996)
- Monohydroxyethylrutoside, a dose-dependent cardioprotective agent, does not affect the antitumor activity of doxorubicin. van Acker, S.A., Boven, E., Kuiper, K., van den Berg, D.J., Grimbergen, J.A., Kramer, K., Bast, A., van der Vijgh, W.J. Clin. Cancer Res. (1997)
- 6- and 7-substituted 2-[2'-(dimethylamino)ethyl]-1,2-dihydro-3H-dibenz[de,h] isoquinoline-1,3-diones: synthesis, nucleophilic displacements, antitumor activity, and quantitative structure-activity relationships. Sami, S.M., Dorr, R.T., Sòlyom, A.M., Alberts, D.S., Iyengar, B.S., Remers, W.A. J. Med. Chem. (1996)